The in vitro effects of advanced glycation end products on basophil functions

International Archives of Allergy and Immunology

Volumn 155, Issue SUPPL. 1, 2011, Pages 64-70

  Han, Kaiyu ^a   Suzukawa, Maho ^a   Yamaguchi, Masao ^a   Sugimoto, Naoya ^a   Nakase, Yuko ^a   Toda, Takako ^a   Nagase, Hiroyuki ^a   Ohta, Ken ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced glycation end products; Apoptosis; Basophils; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; CD11B ANTIGEN; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; APOPTOSIS; BASOPHIL; BASOPHIL DEGRANULATION; CELL FUNCTION; CELL SURFACE; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LONGEVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANTIGENS, CD11B; APOPTOSIS; BASOPHIL DEGRANULATION TEST; BASOPHILS; CELL DEGRANULATION; CELL SURVIVAL; CELLS, CULTURED; GLYCOSYLATION END PRODUCTS, ADVANCED; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-3; INTERLEUKIN-5; INTERLEUKIN-6; INTERLEUKIN-8; RECEPTORS, IMMUNOLOGIC; SERUM ALBUMIN;

EID: 79958077765     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000327298     Document Type: Conference Paper

References (30)

1. Min B, Prout M, Hu-Li J, Zhu J, Jankovic D, Morgan ES, Urban JF Jr, Dvorak AM, Finkelman FD, LeGros G, Paul WE: Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite. J Exp Med 2004;200:507-517. (Pubitemid 39121907)
2. Ohnmacht C, Voehringer D: Basophil effector function and homeostasis during helminth infection. Blood 2009;113:2816-2825.
3. Mukai K, Matsuoka K, Taya C, Suzuki H, Yokozeki H, Nishioka K, Hirokawa K, Etori M, Yamashita M, Kubota T, Minegishi Y, Yonekawa H, Karasuyama H: Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity 2005;23:191-202. (Pubitemid 41169288)
4. Khodoun MV, Orekhova T, Potter C, Morris S, Finkelman FD: Basophils initiate IL-4 production during a memory T-dependent response. J Exp Med 2004;200:857-870. (Pubitemid 39362922)
5. Tsujimura Y, Obata K, Mukai K, Shindou H, Yoshida M, Nishikado H, Kawano Y, Minegishi Y, Shimizu T, Karasuyama H: Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity 2008;28:581-589.
6. Denzel A, Maus UA, Rodriguez Gomez M, Moll C, Niedermeier M, Winter C, Maus R, Hollingshead S, Briles DE, Kunz-Schughart LA, Talke Y, Mack M: Basophils enhance immunological memory responses. Nat Immunol 2008;9:733-742. (Pubitemid 351859156)
7. Visness CM, London SJ, Daniels JL, Kaufman JS, Yeatts KB, Siega-Riz AM, Liu AH, Calatroni A, Zeldin DC: Association of obesity with IgE levels and allergy symptoms in children and adolescents: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol 2009;123:1163-1169.
8. Al-Shawwa BA, Al-Huniti NH, DeMattia L, Gershan W: Asthma and insulin resistance in morbidly obese children and adolescents. J Asthma 2007;44:469-473. (Pubitemid 47123753)
9. Wendt T, Tanji N, Guo J, Hudson BI, Bierhaus A, Ramasamy R, Arnold B, Nawroth PP, Yan SF, D'Agati V, Schmidt AM: Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy. J Am Soc Nephrol 2003;14:1383-1395. (Pubitemid 36514678)
10. Yan SF, Ramasamy R, Schmidt AM: The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res 2010;106:842-853.
11. Demling N, Ehrhardt C, Kasper M, Laue M, Knels L, Rieber EP: Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells. Cell Tissue Res 2006;323:475-488. (Pubitemid 43228103)
12. Suzukawa M, Iikura M, Koketsu R, Nagase H, Tamura C, Komiya A, Nakae S, Matsushima K, Ohta K, Yamamoto K, Yamaguchi M: An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J Immunol 2008;181:5981-5989.
13. Yoshimura-Uchiyama C, Yamaguchi M, Nagase H, Fujisawa T, Ra C, Matsushima K, Iwata T, Igarashi T, Yamamoto K, Hirai K: Comparative effects of basophil-directed growth factors. Biochem Biophys Res Commun 2003;302:201-206. (Pubitemid 36397907)
14. Iikura M, Yamaguchi M, Fujisawa T, Miyamasu M, Takaishi T, Morita Y, Iwase T, Moro I, Yamamoto K, Hirai K: Secretory IgA induces degranulation of IL-3-primed basophils. J Immunol 1998;161:1510-1515. (Pubitemid 28380584)
15. Yoshimaru T, Suzuki Y, Inoue T, Nishida S, Ra C: Extracellular superoxide released from mitochondria mediates mast cell death by advanced glycation end products. Biochim Biophys Acta 2008;1783:2332-2343.
16. Sick E, Brehin S, Andre P, Coupin G, Landry Y, Takeda K, Gies JP: Advanced glycation end products (ages) activate mast cells. Br J Pharmacol 2010;161:442-455.
17. Hirai K, Miyamasu M, Takaishi T, Morita Y: Regulation of the function of eosinophils and basophils. Crit Rev Immunol 1997;17:325-352. (Pubitemid 27268460)
18. Bochner BS, McKelvey AA, Sterbinsky SA, Hildreth JE, Derse CP, Klunk DA, Lichtenstein LM, Schleimer RP: IL-3 augments adhesiveness for endothelium and CD11b expression in human basophils but not neutrophils. J Immunol 1990;145:1832-1837. (Pubitemid 20336751)
19. Gottsater A, Szelag B, Kangro M, Wroblewski M, Sundkvist G: Plasma adiponectin and serum advanced glycated end-products increase and plasma lipid concentrations decrease with increasing duration of type 2 diabetes. Eur J Endocrinol 2004;151:361-366. (Pubitemid 39307324)
20. Makita Z, Vlassara H, Cerami A, Bucala R: Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 1992;267:5133-5138.
21. Liu Y, Liang C, Liu X, Liao B, Pan X, Ren Y, Fan M, Li M, He Z, Wu J, Wu Z: AGEs increased migration and inflammatory responses of adventitial fibroblasts via RAGE, MAPK and NF-kappaB pathways. Atherosclerosis 2010;208:34-42.
22. Sun C, Liang C, Ren Y, Zhen Y, He Z, Wang H, Tan H, Pan X, Wu Z: Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways. Basic Res Cardiol 2009;104:42-49.
23. Vlassara H: The AGE-receptor in the pathogenesis of diabetic complications. Diabetes Metab Res Rev 2001;17:436-443.
24. Horiuchi S, Higashi T, Ikeda K, Saishoji T, Jinnouchi Y, Sano H, Shibayama R, Sakamoto T, Araki N: Advanced glycation end products and their recognition by macrophage and macrophage-derived cells. Diabetes 1996;45(suppl 3):S73-S76.
25. Peleg AY, Weerarathna T, McCarthy JS, Davis TM: Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev 2007;23:3-13. (Pubitemid 46152480)
26. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW: Infections in patients with diabetes mellitus. N Engl J Med 1999;341:1906-1912.
27. Otton R, Soriano FG, Verlengia R, Curi R: Diabetes induces apoptosis in lymphocytes. J Endocrinol 2004;182:145-156. (Pubitemid 39076910)
28. Tedgui A, Mallat Z: Apoptosis as a determinant of atherothrombosis. Thromb Haemost 2001;86:420-426. (Pubitemid 32663971)
29. Ferhani N, Letuve S, Kozhich A, Thibaudeau O, Grandsaigne M, Maret M, Dombret MC, Sims GP, Kolbeck R, Coyle AJ, Aubier M, Pretolani M: Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181:917-927.
30. Morbini P, Villa C, Campo I, Zorzetto M, Inghilleri S, Luisetti M: The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Mod Pathol 2006;19:1437-1445.